Search
ROG:VX: APHINITY headline positive but await full data
Awaiting full data: Roche announced that APHINITY met its primary endpoint , but as expected details are to be published at an upcoming medical meeting. We look to the data to confirm if all patients benefit from the addition of Perjeta...
